Black-footed ferrets given experimental COVID vaccine elkodaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elkodaily.com Daily Mail and Mail on Sunday newspapers.
December 23, 2020
In late summer, as researchers accelerated the first clinical trials of Covid-19 vaccines for humans, a group of scientists in Colorado worked to inoculate a far more fragile species.
About 120 black-footed ferrets, among the most endangered mammals in North America, were injected with an experimental Covid-19 vaccine aimed at protecting the small, weasel-like creatures rescued from the brink of extinction four decades ago.
The effort came months before US Department of Agriculture officials began accepting applications from veterinary drugmakers for a commercial vaccine for minks, a close cousin of the ferrets. Farmed minks, raised for their valuable fur, have died by the tens of thousands in the US and been culled by the millions in Europe after catching the Covid-19 virus from infected humans.
At risk of extinction, black-footed ferrets get experimental COVID vaccine
In late summer, as researchers accelerated the first clinical trials of COVID-19 vaccines for humans, a group of scientists in Colorado worked to inoculate a far more fragile species.
About 120 black-footed ferrets, among the most endangered mammals in North America, were injected with an experimental COVID vaccine aimed at protecting the small, weasel-like creatures rescued from the brink of extinction four decades ago.
The effort came months before U.S. Department of Agriculture officials began accepting applications from veterinary drugmakers for a commercial vaccine for minks, a close cousin of the ferrets. Farmed minks, raised for their valuable fur, have died by the tens of thousands in the U.S. and been culled by the millions in Europe after catching the COVID virus from infected humans.
Glimmer of hope for vaccine that could eradicate TB reinfection 20 December 2020 - 08:32 Image: Alaister Russell/The Sunday Times
Tuberculosis reinfection may be a thing of the past if a vaccine that is being developed by the University of Cape Town researchers proves successful.
The results from a clinical trial that is investigating a candidate vaccine that prevents the recurrence of TB in people who’ve recovered from the disease shows promise after it was proved safe and induced an immune response when given to cured patients.
The results of the phase 2 trial of the ID93+GLA-SE candidate vaccine, which have been published in the